Venture Round - Lentigen
Investment Firm
Overview
Lentigen Corporation is engaged in the development and commercialization of gene delivery technologies for human diseases.
Announced Date
Jan 02, 2012
Funding Type
Series Unknown
Highlights
Location
United States, North America
Social
N/A
Investor Lead
N/A
Participant Investors
1
| Investor Name |
|---|
 Biomark Capital |
Round Details and Background
Lentigen raised an undisclosed amount on 2012-01-02 in Venture Round
Lentigen Corporation is engaged in the development and commercialization of gene delivery technologies for human diseases.
Company Funding History
2
| Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
|---|---|---|---|---|
| Jan 02, 2012 |  Venture Round - Lentigen | 1 | - | undefined |
| Nov 04, 2010 | Grant - Lentigen | - | 1.2M |
Recent Activity
There is no recent news or activity for this profile.